RYTM Shares Outstanding History



Below is a table of the RYTM shares outstanding history going back to 10/5/2017:

Date RYTM Shares Outstanding
10/5/201725.69M
5/11/201827.53M
8/3/201834.18M
11/8/201834.41M
3/1/201934.43M
4/30/201934.43M
7/25/201934.52M
8/1/201942.94M
10/31/201943.93M
2/28/202044.06M
4/24/202044.09M
7/24/202044.12M
10/23/202044.20M
2/19/202150.18M
4/23/202150.21M
7/26/202150.23M
10/26/202150.27M
2/22/202250.33M
4/27/202250.39M
7/28/202250.72M
11/2/202256.35M
2/22/202356.75M
7/26/202356.90M
11/1/202359.10M
2/23/202460.14M

Also see: RYTM Market Cap History
RYTM YTD Return
RYTM Historical Shares Outstanding:
+14.24% CAGR
RYTM Historical Shares Outstanding: +14.24% CAGR

Mouse over chart for data details
10/5/2017 ...2/23/2024
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company to transform the lives of patients and their families living with rare diseases. Co. is focused on developing IMCIVREE® (setmelanotide), as a medicine designed to treat hyperphagia and severe obesity caused by melanocortin-4 receptor pathway diseases. IMCIVREE is approved by the U.S. Food and Drug Administration for chronic weight management in adult and pediatric patients six years of age and older with monogenic or syndromic obesity due to: proopiomelanocortin, proprotein convertase subtilisin/kexin type 1 or leptin receptor deficiency; or Bardet-Biedl syndrome. We show 25 historical shares outstanding datapoints in our coverage of RYTM's shares outstanding history.

Understanding the changing numbers of RYTM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RYTM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RYTM by allowing them to research RYTM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree RYTM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Rhythm Pharmaceuticals (RYTM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

RYZB Shares Outstanding History
RZLT Shares Outstanding History
SAGE Shares Outstanding History
SANA Shares Outstanding History
SAVA Shares Outstanding History
SBFM Shares Outstanding History
SBPH Shares Outstanding History
SBTX Shares Outstanding History
SCPH Shares Outstanding History
SCPS Shares Outstanding History
More Healthcare companies »

 

RYTM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.